Diabetic neuropathy is regarded as one of the most debilitating outcomes of diabetes
mellitus and may cause pain, decreased motility, and even amputation. Diabetic neuropathy …

Context: Diabetic complications appear to be multifactorial in origin, but in particular, the
biochemical process of advanced glycation, which is accelerated in diabetes as a result of …

Neuropathy is the most common and debilitating complication of diabetes and results in
pain, decreased motility, and amputation. Diabetic neuropathy encompasses a variety of …

The aim of this article is to describe the current and potential clinical translation of
pharmacological inhibitors of poly (ADP-ribose) polymerase (PARP) for the therapy of …

The HMG Co-enzyme inhibitors and new lipid-modifying agents expand their new
therapeutic target options in the field of medical profession. Statins have been described as …

Diabetic retinopathy (DR) and other diabetic vascular complications are the leading cause of
death and disability in patients with suboptimum glycemic control. In the pathogenesis of …

Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes and is
associated with significant morbidity and mortality. DPN is characterized by progressive …

Chronic hyperglycaemia (an abnormally high glucose concentration in the blood) resulting
from defects in insulin secretion/action, or both, is the major hallmark of diabetes in which it …

The morbidity caused by diabetes has traditionally been classified into macro-and
microvascular complications. Although macrovascular complications have received greater …

Diabetic neuropathy is the most common complication of diabetes, affecting 50% of diabetic
patients. Currently, the only treatment for diabetic neuropathy is glucose control and careful …